Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SEPARATE DEVICE APPLICATION FEE FOR CLIA SUBMISSIONS

This article was originally published in The Gray Sheet

Executive Summary

SEPARATE DEVICE APPLICATION FEE FOR CLIA SUBMISSIONS is provided for in a May 17 discussion draft of medical device user fee legislation. While the actual amount is left blank, the revised draft indicates that a separate fee will be levied "for an application submitted under section 353 of the Public Health Service Act," which is the Clinical Laboratories Improvement Amendments of 1988. The initial draft of the legislation made no mention of a specific fee for CLIA applications, instead grouping them with standard application fees ("The Gray Sheet" April 18, p. 3).

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel